<DOC>
	<DOCNO>NCT02546453</DOCNO>
	<brief_summary>The search genetic alteration primary tumor NGS technique follow detection alteration circulate tumor DNA and/or CTC/DTC present peripheral sample ( blood , cerebrospinal fluid , bone marrow , possibly urine ) collect several step treatment could tool monitor response treatment .</brief_summary>
	<brief_title>Use Specific Genetic Alteration Tumoral Cells Identified Next Generation Sequencing Techniques ( NGS ) Follow Peripheral Samples Children With Metastatic and/or High Risk Solid Tumor - NGSKids</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Children metastatic and/or high risk solid tumor , follow pathology : Neuroblastoma , sarcoma , malignant brain tumor ( medulloblastoma , highgrade glioma ) , bone tumor , rhabdoid tumor , others rare tumor Availability freeze tumoral sample ( primary tumor metastasis whatever localization ) diagnosis allow analysis genetic alteration NGS technique Age &lt; 18 year Signed informed consent parent legal representative Patient health care insurance Exclusion Criteria : Age â‰¥ 18 year No sign informed consent parent legal representative</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>high risk solid tumor pediatric , genetic alteration , Metastatic solid tumor pediatric</keyword>
</DOC>